American Well Stock - Analyst sentiment and strategy backdrop midweek
17.06.2026 - 22:57:12 | ad-hoc-news.de
Edited by ad hoc news Operations & Strategy Desk. Verified prior to publication on 06/17/2026, 20:50 UTC. Details in the imprint.
American Well Corp (US03044L1052) remains a niche telehealth name on the Nasdaq with a still loss-making but evolving platform business. With no fresh company filings or major news reported by primary outlets today, the focus midweek shifts to operations, strategy and how analysts view the stock.
All news and key data on American Well stock
Further background, regulatory filings and historical headlines on American Well can be found in the dedicated topic overview on ad-hoc-news.de and via the company’s own investor-relations pages.
How Wall Street rates Amwell
Analyst coverage of American Well remains modest, with data aggregators showing a mix of Hold and Buy ratings and a cautious stance after years of persistent losses. Price targets cluster only slightly above the current share price, indicating muted upside expectations for now.
Consensus revenue forecasts still point to single-digit to low double-digit percentage growth in the coming years, but analysts flag execution risk as health systems rationalize digital-health spending. Net losses are expected to narrow gradually rather than quickly, which keeps sentiment reserved.
Midweek view on operations and strategy
Operationally, American Well presents itself as a software-led telehealth platform, supplying hospitals, health plans and employers with white-label virtual-care technology. Management has emphasized a shift away from lower-margin visit-fee revenue toward recurring software and services fees, aiming for a more scalable profile.
Recent quarterly results highlighted cost-control efforts and a focus on platform migration, while total revenue growth remained relatively soft in the low-single-digit range year-on-year. Against this backdrop, investors pay close attention to contract wins, churn and the pace at which legacy customers adopt the latest platform modules.
How the company makes money
American Well generates revenue primarily from its Converge telehealth platform, where health systems and payers pay recurring subscription and service fees to power virtual urgent care, scheduled specialist visits and behavioral-health consultations. Additional income comes from per-visit fees and implementation projects.
Where the stock trades today
American Well stock trades on Nasdaq under the ticker "AMWL" at about $0.74 as of 06/17/2026, 20:35 UTC.
Key facts on American Well stock
- Company: American Well Corp
- ISIN: US03044L1052
- WKN: A2QK38
- Ticker: AMWL
- Venue: Nasdaq
- Price (as of 06/17/2026, 20:35 UTC): 0.74 USD
- Market cap: 210,000,000 USD (as of 06/17/2026)
- Sector / Industry: Health Care - Health Care Technology / Telehealth
- Index membership: not a member of major benchmarks such as the S&P 500 or Nasdaq-100
- Next earnings date: not officially scheduled
This article was AI-assisted and editorially reviewed. Price and company data without warranty; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Trading securities involves risk up to total loss of capital.
